Dr. Mitchell A Blass is categorized under Infectious Disease Specialists in Atlanta, GA and active since 1981.
Dr. Mitchell A Blass was established in 1981, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Infectious Disease Specialists business, which does work in the B2C market, and is classified as a Infectious Disease Specialists, under code number by the NAICS.
If you are seeking more information, feel free to contact Monique Duke at the company’s single location by writing to 5673 Peachtree Dunwoody Rd
Ste 600, Atlanta, Georgia GA 30342 or by phoning (404) 256-4111. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Dr. Mitchell A Blass |
| Contact Person: | Monique Duke |
| Address: | 5673 Peachtree Dunwoody Rd Ste 600, Atlanta, Georgia 30342 |
| Phone Number: | (404) 256-4111 |
| Website Address: | georgiaid.net |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 1981 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Infectious Disease Specialists |
| Share This Business: |
Dr. Mitchell A Blass was started in 1981 to provide professional Infectious Disease Specialists under the SIC code and NAICS code . Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Monique Duke for inquiries that concern Dr. Mitchell A Blass by calling the company number (404) 256-4111, as your correspondence is most welcome.
Additionally, the physical location of the single location of Dr. Mitchell A Blass can be found at the coordinates 33.90933,-84.35227 as well as the street address 5673 Peachtree Dunwoody Rd
Ste 600 in Atlanta, Georgia 30342.
For its online presence, you may visit Dr. Mitchell A Blass’s website at georgiaid.net and engage with its social media outlets through on Twitter and on Facebook.